Print

GTx, Inc. (GTXI)Announces Poster Presentation on the Prevalence and Impact of Hypogonadism in Cancer Patients with Muscle Wasting from its Phase IIb Enobosarm Clinical Trial at the Endocrine Society’s 2012 Annual Meeting  
6/13/2012 10:14:21 AM

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that Dr. Adrian Sandra Dobs, Director, John Hopkins Clinical Research Network Professor of Medicine and Oncology at the John Hopkins University School of Medicine, will present her abstract on the “Prevalence and Impact of Hypogonadism in Cancer Patients with Muscle Wasting in a Phase IIb Enobosarm Trial” in a poster presentation during the 2012 Annual Meeting of the Endocrine Society.
//-->